Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Total Non-Current Liabilities (2021)

Bioregenx has reported Total Non-Current Liabilities over the past 1 years, most recently at $151399.0 for Q4 2021.

  • For Q4 2021, Total Non-Current Liabilities changed N/A year-over-year to $151399.0; the TTM value through Dec 2021 reached $151399.0, changed N/A, while the annual FY2021 figure was $151399.0, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q4 2021 was $151399.0 at Bioregenx.
  • Over five years, Total Non-Current Liabilities peaked at $151399.0 in Q4 2021 and troughed at $151399.0 in Q4 2021.